Health Care/Hospital
Geberit's Award-winning Mapress Stainless Steel Piping Certified for Use in Hong Kong
SINGAPORE, Sept. 15, 2020 /PRNewswire/ -- Geberit Group, the European market leader in sanitary products, announces that Geberit Mapress Stainless Steel supply system is approved for use inHong Kong. The stainless steel, non-soldered alternative is widely used inAsia as a safer, more durable alt...
2020-09-15 08:00
3887
Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
SINGAPORE, Sept. 15, 2020 /PRNewswire/ -- Concept Medical Inc.,
2020-09-15 03:41
3394
Seelos Announces Issuance of a New Patent and an Additional Notice of Allowance in Japan for Intranasal Racemic Ketamine (SLS-002)
Patents Further Strengthen Global Intellectual Property Portfolio in Psychiatry NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare ...
2020-09-14 21:00
7659
TIKOMED'S ILB(R) restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants
VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury ...
2020-09-14 20:35
1796
NASIR-HCC: Phase 2 study of Sirtex Medical SIR-Spheres(R) Y-90 resin microspheres followed by Nivolumab therapy demonstrates favorable safety and tolerability profile at ILCA 2020
WOBURN, Massachusetts, Sept. 14, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapy, SIR-Spheres®Y-90 resin microspheres, is pleased to report that positive trial data from the NASIR-HCC Study was reported by ProfessorBruno Sangro at the ...
2020-09-14 20:00
1651
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Granted Orphan Drug Designation by the FDA for the Treatment of Gastric Cancer
SUZHOU, China and ROCKVILLE, Md., Sept. 14, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug ...
2020-09-14 18:35
1897
Innovent and Lilly Jointly Announce Results of Six Clinical Studies of TYVYT® (sintilimab injection) to be Presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
SAN FRANCISCO and SUZHOU, China, Sept. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major disea...
2020-09-14 18:00
12634
Countering counterfeit medicines in the fast-paced world of e-commerce
BANGKOK, Sept. 14, 2020 /PRNewswire/ -- Research shows that counterfeit medicine cannot cure illnesses and can cause moreharm to your health. Counterfeit medicines have been in the market for a long time, and without sufficient awareness, consumption of these substances can lead to unexpected sy...
2020-09-14 16:59
3343
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer * Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib† from largest ongoing st...
2020-09-14 10:41
2468
Global Fund Partnership Has Saved 38 Million Lives - but COVID-19 Could Wipe Out Progress
GENEVA, Sept. 14, 2020 /PRNewswire/ -- A new report by the Global Fund to Fight AIDS, Tuberculosis and Malaria is a call to action to urgently invest to protect decades of progress against HIV, TB and malaria that are being derailed as a knock-on effect of the COVID-19 pandemic. According to ...
2020-09-14 10:39
3437
Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist
SHANGHAI, Sept. 14, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that it has filed investigational new drug application (IND) with US FDA for its non-alcoholic steatohepatitis (NASH) drug candidate ASC42. ASC42 is an in-...
2020-09-14 08:30
3397
Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market
SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more th...
2020-09-14 08:17
3373
5 years, 500 million USD, and nearly 1,000 people: Cytiva invests for global capacity expansion
* Total planned investment is around 500 million USD over five years to raise manufacturing capacity * Continues long-term strategy of increasing capacity to respond to growing industry demand and new market opportunities * Cytiva hiring nearly 1,000 personnel in Austria, China, Singapore, S...
2020-09-14 03:00
2977
Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting
LONDON, Sept. 12, 2020 /PRNewswire/ -- Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research: Dr Andrew Pitsillides, Professor of Skeletal Dynamics at the Royal Veterinary College, London presented 'NaQuinate: A Drug that Selectively Synergize...
2020-09-12 05:00
6129
SK Biopharmaceuticals Initiates Clinical Development Program for Cenobamate in Asia
Phase 3 clinical trial to support registrational filings in China and Japan Company on track to expand presence in Asia, reflecting its commitment to reach more people with epilepsy worldwide PANGYO, GYEONGGI PROVINCE, Korea, Sept. 12, 2020 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a glo...
2020-09-12 03:13
5377
Harbour BioMed and Hualan Genetic Announced Collaboration to Develop Multiple Innovative Antibody Programs
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, SUZHOU,China and XINXIANG, China, Sept. 11, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company today announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd (Hualan Geneti...
2020-09-11 21:33
7223
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical trial program Data f...
2020-09-11 20:00
5681
Booming Demand for Innodisk's CAN Bus Solutions Amid Pandemic and Autonomous Vehicle Trend
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Innodisk's CAN bus expansion modules are taking the world by storm. Unprecedented demand for autonomous vehicle technology amid the ongoing COVID-19 pandemic and continued growth of industrial automation and smart healthcare mean that Innodisk's industry-le...
2020-09-11 15:45
3748
The Air Liquide Foundation supports 10 scientific projects and 21 social emergency aid projects in the context of its Covid-19 Initiative
PARIS, Sept. 11, 2020 /PRNewswire/ -- In response to the Health crisis, the Air Liquide Foundation launched as early asMarch 2020 the Covid-19 Initiative. More than 2million euros have been mobilized over two years, with a double objective: to support scientific research projects and to reinforce...
2020-09-11 11:53
3433
Sai Life Sciences expands suite of cellular analysis platforms in Cambridge, MA
CAMBRIDGE, Mass. and HYDERABAD, India, Sept. 11, 2020 /PRNewswire/ -- Sai Life
Sciences, one ofIndia's fastest growing Contract Development & Manufacturing
Organizations (CDMOs)
2020-09-11 11:30
4062
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5482
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4443
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4034
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3294
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
3039